A busy Wednesday for small-cap technology names was headlined by a major contract win at Shearwater Group and a significant operational milestone at MedPal AI, while board changes, an AI partnership, a disposal, and a refinancing update rounded out a news-heavy session across the sector.
Iconic Labs brings health economist onto board
Iconic Labs (AIM:ICON) appointed Bertalan Jászkuti, a life-sciences finance specialist from Syreon Research Institute, as a non-executive director, with the move sending shares up 12.1% to 1.85p. The appointment follows the departure of Victor Humberdot, who stepped down after two years on the board. Jászkuti's background in health economics signals an intent to sharpen the company's positioning at the intersection of healthcare and capital markets.
Shearwater lands £25m contract extension with long-standing customer
Shearwater Group (AIM:SWG) secured a £25m contract extension with an existing customer, describing the award as a reflection of its technology capabilities and the depth of a partnership built over many years. Group Chief Executive Phil Higgins pointed to the quality of service delivery as central to retaining the business. The announcement drove shares 16.2% higher to 43.0p, making it the sharpest single-day move in the sector on the day.
Catenai investee Alludium named tech partner for AgenticInvestor
Catenai (AIM:CTAI) disclosed that its investee company Alludium has been selected as the technology partner underpinning the new AgenticInvestor platform, an open-source tool targeting private-market investors. Alludium's Agent Operating System was used to build and test the platform's AI-driven workflows. Catenai shares were unchanged at 0.175p, with the announcement representing a commercial validation of Alludium's technology rather than a direct revenue event for the parent.
MedPal AI opens NHS-approved robotic dispensing hub in Runcorn
MedPal AI (AIM:MPAL) opened its 23,000 sq ft Sarus Court facility in Runcorn, described as the largest robotic dispensing site of its kind, with NHS approval in place and capacity to process more than 10,000 prescription items per day. That throughput figure places it above the monthly volumes recorded by Boots and Well.co.uk on the PharmData leaderboard. Shares rose 5.0% to 4.2p on the news, which marks a material step in the company's push to scale automated pharmacy infrastructure.
Amcomri divests Premier Limpet adhesive tape unit for up to £10.1m
Amcomri Group (AIM:AMCO) agreed to sell its Premier Limpet adhesive tape division for a consideration of up to £10.1m, with Chief Executive Hugh Whitcomb framing the disposal as evidence of the group's "Buy, Improve, Build" strategy delivering returns. The sale trims the group's portfolio as management focuses capital on higher-priority units. Shares were flat at 148.0p.
Seeing Machines refinancing extends beyond FY2026 on lender interest
Seeing Machines (AIM:SEE) updated the market on its refinancing process, confirming it will run beyond the end of the current financial year as the company works to secure what it called the "most attractive terms" given strong lender interest. The extended timeline reflects a deliberate approach rather than any difficulty in finding counterparties. Shares edged 2.3% higher to 4.37p as investors appeared to take comfort from the characterisation of lender appetite.
